BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28913947)

  • 1. Extreme chromosome 17 copy number instability is a prognostic factor in patients with gastroesophageal adenocarcinoma: A retrospective cohort study.
    Birkness JE; Spada NG; Miller C; Luketich JD; Nason KS; Sun W; Davison JM
    Genes Chromosomes Cancer; 2018 Jan; 57(1):28-34. PubMed ID: 28913947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic instability and DNA ploidy are linked to DNA copy number aberrations of 8p23 and 22q11.23 in gastric cancers.
    Kawauchi S; Furuay T; Uchiyama T; Adachi A; Okada T; Nakao M; Oga A; Uchida K; Sasaki K
    Int J Mol Med; 2010 Sep; 26(3):333-9. PubMed ID: 20664948
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhang L; Hamdani O; Gjoerup O; Cho-Phan C; Snider J; Castellanos E; Nimeiri H; Frampton G; Venstrom JM; Oxnard G; Klempner SJ; Schrock AB
    JCO Precis Oncol; 2022 Jan; 6():e2100330. PubMed ID: 35050711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers.
    Furuya T; Uchiyama T; Murakami T; Adachi A; Kawauchi S; Oga A; Hirano T; Sasaki K
    Clin Cancer Res; 2000 Jul; 6(7):2815-20. PubMed ID: 10914729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER2 in situ hybridization in gastric and gastroesophageal adenocarcinoma: comparison of automated dual ISH to FISH.
    Grin A; Brezden-Masley C; Bauer S; Streutker CJ
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):561-6. PubMed ID: 23455182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
    Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
    Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2 Genetic Heterogeneity in Gastric Cancer: Evaluation According to the College of American Pathologists Breast Cancer Criteria.
    Treacy AD; Karamchandani JR; Streutker CJ; Grin A
    Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):628-32. PubMed ID: 25611242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2 status in gastric/gastro-oesophageal junctional cancers: should determination of gene amplification by SISH use HER2 copy number or HER2: CEP17 ratio?
    Kumarasinghe MP; de Boer WB; Khor TS; Ooi EM; Jene N; Jayasinghe S; Fox SB
    Pathology; 2014 Apr; 46(3):184-7. PubMed ID: 24614718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
    Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
    Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
    Silva ANS; Saito Y; Yoshikawa T; Oshima T; Hayden JD; Oosting J; Earle S; Hewitt LC; Slaney HL; Wright A; Inam I; Langley RE; Allum W; Nankivell MG; Hutchins G; Cunningham D; Grabsch HI
    Br J Surg; 2022 Feb; 109(3):291-297. PubMed ID: 35179206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of centromere 17 copy number gain in breast cancer depends on breast cancer subtype.
    Lee K; Jang MH; Chung YR; Lee Y; Kang E; Kim SW; Kim YJ; Kim JH; Kim IA; Park SY
    Hum Pathol; 2017 Mar; 61():111-120. PubMed ID: 27989787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial.
    Hecht JR; Bang YJ; Qin SK; Chung HC; Xu JM; Park JO; Jeziorski K; Shparyk Y; Hoff PM; Sobrero A; Salman P; Li J; Protsenko SA; Wainberg ZA; Buyse M; Afenjar K; Houé V; Garcia A; Kaneko T; Huang Y; Khan-Wasti S; Santillana S; Press MF; Slamon D
    J Clin Oncol; 2016 Feb; 34(5):443-51. PubMed ID: 26628478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal instability is a risk factor for poor prognosis of adenocarcinoma of the lung: Fluorescence in situ hybridization analysis of paraffin-embedded tissue from Korean patients.
    Choi CM; Seo KW; Jang SJ; Oh YM; Shim TS; Kim WS; Lee DS; Lee SD
    Lung Cancer; 2009 Apr; 64(1):66-70. PubMed ID: 18814932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma.
    Davison JM; Yee M; Krill-Burger JM; Lyons-Weiler MA; Kelly LA; Sciulli CM; Nason KS; Luketich JD; Michalopoulos GK; LaFramboise WA
    PLoS One; 2014; 9(1):e79079. PubMed ID: 24454681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma - significance of potentially retained stemness.
    Yoon JY; Brezden-Masley C; Streutker CJ
    BMC Cancer; 2020 Sep; 20(1):860. PubMed ID: 32894084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes.
    Geng Q; Lao J; Zuo X; Chen S; Bei JX; Xu D
    J Pathol; 2020 Nov; 252(3):263-273. PubMed ID: 32715475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications.
    Personeni N; Baretti M; Bozzarelli S; Spaggiari P; Rubino L; Tronconi MC; Fumagalli Romario U; Rosati R; Giordano L; Roncalli M; Santoro A; Rimassa L
    Gastric Cancer; 2017 May; 20(3):428-437. PubMed ID: 27530622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interphase cytogenetics of gastric and esophageal adenocarcinomas.
    Rao PH; Mathew S; Lauwers G; Rodriguez E; Kelsen DP; Chaganti RS
    Diagn Mol Pathol; 1993 Dec; 2(4):264-8. PubMed ID: 8118604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison.
    Koopman T; Smits MM; Louwen M; Hage M; Boot H; Imholz AL
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1343-51. PubMed ID: 25544671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis.
    Fassan M; Pizzi M; Realdon S; Balistreri M; Guzzardo V; Zagonel V; Castoro C; Mastracci L; Farinati F; Nitti D; Zaninotto G; Rugge M
    Hum Pathol; 2013 Sep; 44(9):1804-10. PubMed ID: 23618359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.